Literature DB >> 30120609

NLRP1 promotes TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.

Jing Zong1,2, Hao Zhang1,2, Fang-Fang Li1,2, Kai Liang1,2, Jia-Li Liu1,2, Lu-Hong Xu1,2, Wen-Hao Qian3,4.   

Abstract

Nuclear localization leucine-rich-repeat protein 1 (NLRP1) is a member of Nod-like receptors (NLRs) family. Recent studies have reported that NLRP1 is involved in various diseases, especially in cardiovascular diseases. However, the effect of NLRP1 on cardiac fibrosis remains unclear. In this study, NLRP1 overexpression and NLRP1 silencing constructs were transfected into neonatal rat cardiac fibroblasts induced by TGF-β1 for 48 h to investigate the effect of NLRP1 in cardiac fibrosis and its molecular mechanisms. Cardiac fibroblasts were transfected with NLRP1 and then cultured in the presence and absence of TGF-β1and Smad3 inhibitor (SIS3). Our data indicated that NLRP1 not only promoted fibroblast activation and myofibroblast differentiation, but also upregulated the mRNA and protein levels of α-SMA in the TGF-β1-treated neonatal rat cardiac fibroblasts. Overexpressing NLRP1 in TGF-β1-induced cardiac fibroblasts upregulated the mRNA and protein levels of Collagen I, Collagen III, and connective tissue growth factor. Moreover, NLRP1 upregulated the protein levels of Smad2, Smad3, and Smad4 in nuclei of fibroblasts, and attenuated levels of phosphorylated Smad2 and Smad3 in the cytoplasm of fibroblasts induced by TGF-β1. In addition, the increase in fibrotic genes and Smad proteins was significantly reduced in the presence of SIS3. Our findings illustrated that NLRP1 promoted myofibroblast differentiation and excessive ECM production in TGF-β1-induced neonatal cardiac fibroblasts through directly targeting TGF-β1/Smad signaling pathways.

Entities:  

Keywords:  Cardiac fibroblasts; Fibrosis; NLRP1; TGF-β1; TGF-β1/Smad

Mesh:

Substances:

Year:  2018        PMID: 30120609     DOI: 10.1007/s10735-018-9789-9

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  41 in total

1.  Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.

Authors:  Jochen Tillmanns; Daniel Hoffmann; Yasmin Habbaba; Jan D Schmitto; Daniel Sedding; Daniela Fraccarollo; Paolo Galuppo; Johann Bauersachs
Journal:  J Mol Cell Cardiol       Date:  2015-08-28       Impact factor: 5.000

Review 2.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

3.  High throughput screening identifies ATP-competitive inhibitors of the NLRP1 inflammasome.

Authors:  Philip A Harris; Chaya Duraiswami; Donald T Fisher; James Fornwald; Sandra J Hoffman; Glenn Hofmann; Ming Jiang; Ruth Lehr; Patricia M McCormick; Leng Nickels; Benjamin Schwartz; Zining Wu; Guofeng Zhang; Robert W Marquis; John Bertin; Peter J Gough
Journal:  Bioorg Med Chem Lett       Date:  2015-05-19       Impact factor: 2.823

Review 4.  TGF-β signaling in fibrosis.

Authors:  Anna Biernacka; Marcin Dobaczewski; Nikolaos G Frangogiannis
Journal:  Growth Factors       Date:  2011-07-11       Impact factor: 2.511

5.  NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload.

Authors:  Jing Zong; Mohamed Salim; Heng Zhou; Zhou-yan Bian; Jia Dai; Yuan Yuan; Wei Deng; Jie-yu Zhang; Rui Zhang; Qing-qing Wu; Qi-zhu Tang
Journal:  Lab Invest       Date:  2013-08-19       Impact factor: 5.662

Review 6.  Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease.

Authors:  Alison K Schroer; W David Merryman
Journal:  J Cell Sci       Date:  2015-04-27       Impact factor: 5.285

7.  NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis.

Authors:  María Fernández-Velasco; Patricia Prieto; Verónica Terrón; Gemma Benito; Juana M Flores; Carmen Delgado; Carlos Zaragoza; Begoña Lavin; Mónica Gómez-Parrizas; Eduardo López-Collazo; Paloma Martín-Sanz; Lisardo Boscá
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 8.  Inflammasomes: current understanding and open questions.

Authors:  Franz Bauernfeind; Andrea Ablasser; Eva Bartok; Sarah Kim; Jonathan Schmid-Burgk; Taner Cavlar; Veit Hornung
Journal:  Cell Mol Life Sci       Date:  2010-10-31       Impact factor: 9.207

9.  The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease.

Authors:  Marina Saresella; Francesca La Rosa; Federica Piancone; Martina Zoppis; Ivana Marventano; Elena Calabrese; Veronica Rainone; Raffaello Nemni; Roberta Mancuso; Mario Clerici
Journal:  Mol Neurodegener       Date:  2016-03-03       Impact factor: 14.195

10.  Investigation of cardiac fibroblasts using myocardial slices.

Authors:  Filippo Perbellini; Samuel A Watson; Martina Scigliano; Samha Alayoubi; Sebastian Tkach; Ifigeneia Bardi; Nicholas Quaife; Christopher Kane; Neil P Dufton; André Simon; Markus B Sikkel; Giuseppe Faggian; Anna M Randi; Julia Gorelik; Sian E Harding; Cesare M Terracciano
Journal:  Cardiovasc Res       Date:  2018-01-01       Impact factor: 10.787

View more
  8 in total

Review 1.  The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis.

Authors:  Carol M Artlett
Journal:  Biomolecules       Date:  2022-04-26

2.  [Expression of NLRP1 inflammasomes in myocardial tissue of diabetic rats].

Authors:  Li Rong; Shuo Sun; Feiyu Zhu; Yi Zhao; Qin Gao; Heng Zhang; Bi Tang; Hongju Wang; Pinfang Kang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

Review 3.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

4.  Long noncoding RNA H19 suppresses cardiac hypertrophy through the MicroRNA-145-3p/SMAD4 axis.

Authors:  Hao Wang; Xiaoqing Lian; Wei Gao; Jie Gu; Haojie Shi; Yao Ma; Yafei Li; Yi Fan; Qiming Wang; Liansheng Wang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

5.  MiR-375-3p Promotes Cardiac Fibrosis by Regulating the Ferroptosis Mediated by GPX4.

Authors:  Yu Zhuang; Dicheng Yang; Sheng Shi; Limin Wang; Min Yu; Xiangdong Meng; Yongliang Fan; Ren Zhou; Feng Wang
Journal:  Comput Intell Neurosci       Date:  2022-04-22

6.  TRIM25 Rescues Against Doxorubicin-Induced Pyroptosis Through Promoting NLRP1 Ubiquitination.

Authors:  Xiaxia Wang; Zhexun Lian; Yiping Ge; Dongqiang Yu; Shan Li; Kai Tan
Journal:  Cardiovasc Toxicol       Date:  2021-07-27       Impact factor: 3.231

Review 7.  Inflammasomes and Fibrosis.

Authors:  Wen-Juan Zhang; Shu-Juan Chen; Shun-Chang Zhou; Su-Zhen Wu; Hui Wang
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

8.  hUMSCs regulate the differentiation of ovarian stromal cells via TGF-β1/Smad3 signaling pathway to inhibit ovarian fibrosis to repair ovarian function in POI rats.

Authors:  Linlu Cui; Hongchu Bao; Zhongfeng Liu; Xuejing Man; Hongyuan Liu; Yun Hou; Qianqian Luo; Siyuan Wang; Qiang Fu; Hongqin Zhang
Journal:  Stem Cell Res Ther       Date:  2020-09-07       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.